Advances in synchrotron XRPD in the pharmaceutical industry discussed at SPS-XRPD-2 and PPXRD-16

Improved Pharma and Excelsus Structural Solutions (Swiss) AG are continuing their collaboration to better enable access to synchrotron facilities for industrial clients, especially for pharmaceutical R&D.  At the conference, we discussed recent scientific advances, provided instruction on XRPD and pairwise distribution function (PDF) analysis, and facilitated discussions focused on establishing guidelines for the analysis of amorphous materials.

 

2019-08-17T04:05:58+00:00